Delivery Order SPE2DB24D2012-SPE2DB25FBWNZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) with a ceiling value of $2,330.76. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,524.88 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,687.81 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Kerendia 10 mg, a pharmaceutical product used in the treatment of chronic kidney disease. This competitively awarded, firm fixed-price contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,930.67 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.78 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order and functions as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.03 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) on July 24, 2025, with completion expected by July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Kerendia 10 mg tablets (30-count units). This firm fixed-price delivery order, valued at $15,382.34, was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at the vendor's...
- This delivery order, awarded July 29, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30 tablets of Kerendia 20 mg with a contract ceiling value of $3,042.18 and a firm fixed price structure. The order is scheduled for completion by July 30, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract representing a routine pharmaceutical procurement to support federal medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,108.44 award is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, in support of military treatment programs. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a...
- The Defense Logistics Agency (DLA) awarded a $3,982.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count) with an ultimate completion date of August 4, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems and is...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWNZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Kerendia 10 mg tablets (90-count units) with a ceiling value of $6,552.19. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and is classified as a non-set-aside contract, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This award is part of AmerisourceBergen's ongoing pharmaceutical supply relationship with the Defense Logistics Agency, which holds a comprehensive IDC valued at $999,999,999.00 through December 2026 under the Troop Support Medical contract (SPE2DX). AmerisourceBergen serves as a major pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Kerendia, a medication used in the treatment of chronic kidney disease associated with type 2 diabetes, represents one of the specialized pharmaceutical products the company delivers through its federal supply contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/30/25 |